Argent Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,555
Closed -$929K 205
2020
Q2
$929K Sell
20,555
-6,800
-25% -$305K 0.04% 141
2020
Q1
$1.05M Sell
27,355
-17,480
-39% -$805K 0.05% 121
2019
Q4
$2.08M Buy
+44,835
New +$1.94M 0.07% 110
2017
Q4
Sell
-47,977
Closed -$1.58M 223
2017
Q3
$1.58M Sell
47,977
-74,760
-61% -$2.59M 0.06% 127
2017
Q2
$4.11M Sell
122,737
-9,850
-7% -$294K 0.16% 77
2017
Q1
$3.84M Sell
132,587
-43,070
-25% -$1.07M 0.15% 81
2016
Q4
$3.93M Sell
175,657
-49,525
-22% -$968K 0.16% 80
2016
Q3
$4.18M Sell
225,182
-23,720
-10% -$447K 0.18% 68
2016
Q2
$4.06M Sell
248,902
-81,725
-25% -$1.2M 0.18% 65
2016
Q1
$3.86M Buy
330,627
+37,455
+13% +$419K 0.18% 67
2015
Q4
$3.42M Buy
293,172
+133,847
+84% +$1.69M 0.16% 74
2015
Q3
$1.95M Sell
159,325
-34,475
-18% -$440K 0.1% 95
2015
Q2
$1.83M Buy
+193,800
New +$1.79M 0.08% 112

Other funds holding BEAT

Argent Capital Management's BEAT Position: Q3 2020 in Review

Argent Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2020, closing a stake of 20,555 shares — an estimated $929K sold.

Argent Capital Management first reported a position in BEAT in Q2 2015 and held it in 13 quarters. The position peaked at $4.18M in Q3 2016. 209 funds tracked by Wall St. Rank hold BEAT as of Q3 2020.

  • Argent Capital Management reported no remaining BioTelemetry, Inc. position as of Q3 2020 after selling out during the quarter.
  • Argent Capital Management sold 20,555 BioTelemetry, Inc. shares in Q3 2020, an estimated $929K.
  • Argent Capital Management first reported a position in BioTelemetry, Inc. in Q2 2015 and held it in 13 quarters.
  • Argent Capital Management's BioTelemetry, Inc. position peaked at $4.18M in Q3 2016.
  • 209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2020.

Based on Argent Capital Management's 13F filing for Q3 2020, filed 10 Nov 2020.